Open-angle glaucoma is linked to an increased risk for early-onset Alzheimer’s disease in middle-aged adults, especially men, a new study shows. Medscape Medical News
Tag: Neurology & Neurosurgery
McDonald Criteria Updates Boost MS Diagnostic Specificity
Dr Andrew Solomon discusses changes to the 2024 McDonald criteria that can improve diagnostic specificity and early detection in multiple sclerosis. Consortium of Multiple Sclerosis Centers
ECTRIMS 2025: Promising Advances in RRMS
Dr Devon Conway reviews new therapies and long-term data showcased at ECTRIMS 2025. Medscape
Long-Term Control of NMOSD With Ravulizumab
For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an unprecedented level of disease control at 3 years. Medscape Medical News
Do You Really See What I See?
Do we all see the same color when we look at a banana? Dr F. Perry Wilson comments on a study that explores the human perception of color. Medscape
Simple, Noninvasive Eye Tracking May Flag Cognitive Decline
Naturalistic gaze patterns appear to be a simple, noninvasive, and reliable indicator of cognitive decline, new research suggests. Medscape Medical News
New Optic Nerve Criteria May Speed MS Diagnosis
Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration is expected to significantly accelerate time to diagnosis. Medscape Medical News
Updated McDonald Criteria for MS Allow Earlier Dx and Tx
Drs Andrew Wilner and Oliver Tobin discuss key features of the updated McDonald criteria and how they change the diagnosis of multiple sclerosis. Medscape Neurology
AAN 2025: The Impact of Updated Diagnostic Criteria in RRMS
Dr Pavan Bhargava comments on the practical implications of the revised diagnostic criteria, which allow for earlier diagnosis. Medscape
New Tool May Flag Visual Perception Problems Post-Stroke
The free tool takes 15 minutes to administer and could increase screening access for stroke survivors and fill an unmet need for health care professionals. Medscape Medical News
Simple Retinal Scan May Help Predict Stroke Risk
Researchers have uncovered vascular “fingerprints” in the eye that are strongly associated with increased risk for stroke. Medscape Medical News
Elevated Stroke Risk Following NAION
Adults with nonarteritic anterior ischemic optic neuropathy have an increased risk for stroke over 10 years follow-up and could benefit from regular monitoring. Medscape Medical News
McDonald Criteria Update Aims to Simplify, Speed MS Diagnosis
MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate. Medscape Medical News
Vision Loss a Dementia Risk Factor? What Do the Data Say?
A recent Lancet report claims nearly half of dementia cases could be prevented by addressing 14 risk factors, including vision loss. But is this recommendation backed by evidence? Let’s explore Medscape Medical News
Could Retinal Changes Be a Harbinger of Parkinson’s?
Changes in retinal tissues known to be associated with Parkinson’s disease may occur up to 7 years before clinical symptoms of the disease appear. Medscape Medical News
Gene Therapy Promising for Hereditary Vision Loss
Patients with a progressive form of Leber hereditary optic neuropathy (LHON) that causes rapid vision loss experienced improvement in their eyesight with an experimental gene therapy. Medscape Medical News
The Case for Including Optic Nerve Lesions in MS Dx Criteria
Experts make the case for inclusion of optic nerve lesions as a key diagnostic measure of MS. MDedge News
Impaired Vision an Overlooked Dementia Risk Factor
Impaired vision is an underrecognized and modifiable dementia risk factor in older adults. Medscape Medical News
Gene Therapy Shows Modest Success for Genetic Blindness
Gene therapy delivered by intravitreal injection can counter visual degeneration associated with Leber hereditary optic neuropathy, new phase 3 trial data suggest. Medscape Medical News
EMA Panel Backs Uplizna for Neuromyelitis Optica
The immunosuppressant inebilizumab is indicated to treat adults with neuromyelitis optica spectrum disorder who are anti-aquaporin 4 immunoglobulin G seropositive. International Approvals